Biogen (BIIB) Dividend Coverage Ratio (2009 - 2020)
Biogen (BIIB) posted Dividend Coverage Ratio of 3396.0 for Q4 2020, up 33481.09% on a QoQ basis from 10.11 in Q3 2020, and up 905.49% year-over-year from 337.74 in Q1 2020.
Powered by 
Analysis
Biogen (BIIB) Dividend Coverage Ratio (2009 - 2020) Analysis & Trends
Biogen has reported Dividend Coverage Ratio for 8 years, with the latest figure at 3396.0 in Q4 2020.
- On a quarterly basis, Dividend Coverage Ratio rose 905.49% year-over-year to 3396.0 in Q4 2020; TTM through Sep 2021 was 27.5, a 60.25% decrease from a year earlier, with the FY2020 full-year figure at 57.12, changed N/A from the prior year.
- Dividend Coverage Ratio was 3396.0 for Q4 2020 at Biogen, up from 10.11 in the prior quarter.
- The five-year high for Dividend Coverage Ratio was 3396.0 in Q4 2020, with the low at 1889.8 in Q4 2018.
- Average Dividend Coverage Ratio over 4 years is 164.77, with a median of 10.11 recorded in 2020.
- The sharpest annual moves came in 2019 and 2020: Dividend Coverage Ratio surged 117.87% in 2019, then surged 905.49% in 2020.
- Over 4 years, Dividend Coverage Ratio stood at 2.47 in 2017, then sank by 76627.42% to 1889.8 in 2018, then soared by 117.87% to 337.74 in 2019, then soared by 905.49% to 3396.0 in 2020.
- The last three Dividend Coverage Ratio figures came in at 3396.0 (Q4 2020), 10.11 (Q3 2020), and 337.74 (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.40 Bn | 197.42 Bn | 7.24 Bn | 1.74 |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn | -10.18 |
| 3 | Vertex Pharmaceuticals | 132.13 Bn | 124.28 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.53 Bn | 74.53 Bn | 3.93 Bn | 13.40 |
| 5 | Argenx Se | 61.72 Bn | 56.54 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.67 Bn | 49.53 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.29 Bn | 30.00 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.03 Bn | 30.03 Bn | 1.16 Mn | - |
| 10 | Insmed | 28.28 Bn | 27.12 Bn | 358.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 3,396.00 |
| Sep 30, 2020 | 10.11 |
| Dec 31, 2019 | 337.74 |
| Dec 31, 2018 | -1,889.80 |
| Sep 30, 2018 | -721.45 |
| Jun 30, 2018 | 18.30 |
| Mar 31, 2017 | 2.47 |
| Sep 30, 2015 | 17.11 |
| Dec 31, 2011 | 101.77 |
| Sep 30, 2011 | 24.94 |
| Dec 31, 2010 | 15.92 |
| Sep 30, 2010 | 13.06 |
| Jun 30, 2010 | -206.48 |
| Mar 31, 2010 | -289.46 |
| Dec 31, 2009 | -42.57 |